Digital Recombinase Polymerase Amplification, Digital Loop‐Mediated Isothermal Amplification, and Digital CRISPR‐Cas Assisted Assay: Current Status, Challenges, and Perspectives
Small · 2023-12 · 19 (49)
DOI: 10.1002/smll.202303398 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Small, online erschienen am 23.08.2023. Verfasst von Weihong Yin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Research Centre for Analytical Instrumentation, Institute of Cyber-Systems and Control, State Key Laboratory of Industrial Control Technology, Zhejia…. Hauptthemen laut MEDLINE: Nucleic Acids, Recombinases. Die Arbeit wurde bisher 112-mal zitiert (Crossref) und nennt 138 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Zhejiang Provincial Natural Science Foundation of China, Zhejiang Provincial Medical and Health Technology.
Abstract (Originalsprache)
Digital nucleic acid detection based on microfluidics technology can quantify the initial amount of nucleic acid in the sample with low equipment requirements and simple operations, which can be widely used in clinical and in vitro diagnosis. Recently, isothermal amplification technologies such as recombinase polymerase amplification (RPA), loop‐mediated isothermal amplification (LAMP), and clustered regularly interspaced short palindromic repeats‐CRISPR associated proteins (CRISPR‐Cas) assisted technologies have become a hot spot of attention and state‐of‐the‐art digital nucleic acid chips have provided a powerful tool for these technologies. Herein, isothermal amplification technologies including RPA, LAMP, and CRISPR‐Cas assisted methods, based on digital nucleic acid microfluidics chips recently, have been reviewed. Moreover, the challenges of digital isothermal amplification and possible strategies to address them are discussed. Finally, future directions of digital isothermal amplification technology, such as microfluidic chip and device manufacturing, multiplex detection, and one‐pot detection, are outlined.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Centre for Analytical Instrumentation, Institute of Cyber-Systems and Control, State Key Laboratory of Industrial Control Technology, Zhejiang University, Hangzhou, 310027, P. R. China.
- Department of Clinical Pharmacology, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People's Hospital, Cancer Center, Zhejiang University School of…
- School of information and Electrical Engineering, Hangzhou City University, Hangzhou, 310015, P. R. China.
ORCID-Profile: Ying Mu
Förderung
- National Natural Science Foundation of China
- Zhejiang Provincial Natural Science Foundation of China
- Zhejiang Provincial Medical and Health Technology
Zitieren
APA
Yin, W., Zhuang, J., Li, J., Xia, L., Hu, K., Yin, J., & Mu, Y. (2023). Digital Recombinase Polymerase Amplification, Digital Loop‐Mediated Isothermal Amplification, and Digital CRISPR‐Cas Assisted Assay: Current Status, Challenges, and Perspectives. Small, 19(49). https://doi.org/10.1002/smll.202303398
Vancouver
Yin W, Zhuang J, Li J, Xia L, Hu K, Yin J, et al. Digital Recombinase Polymerase Amplification, Digital Loop‐Mediated Isothermal Amplification, and Digital CRISPR‐Cas Assisted Assay: Current Status, Challenges, and Perspectives. Small. 2023;19(49). doi:10.1002/smll.202303398
BibTeX
@article{Yin2023,
author = {Yin, Weihong and Zhuang, Jianjian and Li, Jiale and Xia, Liping and Hu, Kai and Yin, Juxin and Mu, Ying},
title = {Digital Recombinase Polymerase Amplification, Digital Loop‐Mediated Isothermal Amplification, and Digital CRISPR‐Cas Assisted Assay: Current Status, Challenges, and Perspectives},
journal = {Small},
year = {2023},
volume = {19},
number = {49},
doi = {10.1002/smll.202303398}
}
EUVIMED